EDP Sciences logo
Subscriber Authentication Point
rechercher
Menu
Accueil Tous les numéros Thérapie, 61 1 (2006) 49-55 Article's citations

Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

Monitoring misuse and abuse of psychoactive substances in France: Insights from substance abuse treatment facilities through the OPPIDUM program

Clémence Lacroix, Elisabeth Frauger, Elisabeth Jouve, Hélène Peyrière and Joëlle Micallef
Therapies 80 (2) 177 (2025)
https://doi.org/10.1016/j.therap.2024.10.054

Augmentation de l’abus de méthylphénidate : repérage et profils sur 13 années

Clémence Guerra, Thomas Soeiro, Clémence Lacroix, Elisabeth Jouve, Joelle Micallef and Elisabeth Frauger
Therapies 77 (6) 713 (2022)
https://doi.org/10.1016/j.therap.2022.03.006

Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution

Mathilde Dupui, Joëlle Micallef and Maryse Lapeyre-Mestre
Therapies 74 (2) 307 (2019)
https://doi.org/10.1016/j.therap.2018.09.078

On Comparison of Clustering Methods for Pharmacoepidemiological Data

Fanny Feuillet, Lise Bellanger, Jean-Benoit Hardouin, Caroline Victorri-Vigneau and Véronique Sébille
Journal of Biopharmaceutical Statistics 25 (4) 843 (2015)
https://doi.org/10.1080/10543406.2014.920855

Signal Identification in Addictovigilance: the Functioning of the French System

Emilie Jouanjus, Valérie Gibaja, Jean-Pierre Kahn, Françoise Haramburu and Amélie Daveluy
Therapies 70 (2) 123 (2015)
https://doi.org/10.2515/therapie/2015011

Comment identifier un signal en addictovigilance ?

Emilie Jouanjus, Valérie Gibaja, Jean-Pierre Kahn, Françoise Haramburu and Amélie Daveluy
Therapies 70 (2) 113 (2015)
https://doi.org/10.2515/therapie/2015009

Les systèmes d’évaluation de l’abus et de la dépendance des médicaments psychoactifs

Sandra Nordmann, Elisabeth Frauger, Vanessa Pauly, et al.
Therapies 66 (3) 263 (2011)
https://doi.org/10.2515/therapie/2011045

Patterns of Methylphenidate Use and Assessment of its Abuse and Diversion in Two French Administrative Areas Using a Proxy of Deviant Behaviour Determined from a Reimbursement Database

Elisabeth Frauger, Vanessa Pauly, François Natali, et al.
CNS Drugs 25 (5) 415 (2011)
https://doi.org/10.2165/11587640-000000000-00000

Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuse

Vanessa Pauly, Elisabeth Frauger, Vincent Pradel, et al.
Drug and Alcohol Dependence 113 (1) 29 (2011)
https://doi.org/10.1016/j.drugalcdep.2010.06.016

Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network

Elisabeth Frauger, Vanessa Pauly, Vincent Pradel, Frank Rouby, Jocelyne Arditti, Xavier Thirion, Maryse Lapeyre Mestre and Joëlle Micallef
Fundamental & Clinical Pharmacology 25 (5) 633 (2011)
https://doi.org/10.1111/j.1472-8206.2010.00882.x

Terminologie utilisée concernant les bases de remboursement de l’assurance maladie en pharmaco-épidémiologie : une harmonisation nécessaire

Karin Martin-Latry and Audrey Cougnard
Thérapie 65 (4) 379 (2010)
https://doi.org/10.2515/therapie/2010047

Assessment of Abuse Potential of Benzodiazepines from a Prescription Database Using ‘Doctor Shopping’ as an Indicator

Vincent Pradel, Catherine Delga, Frank Rouby, Joëlle Micallef and Maryse Lapeyre-Mestre
CNS Drugs 24 (7) 611 (2010)
https://doi.org/10.2165/11531570-000000000-00000

Pharmacoepidemiological research using French reimbursement databases: yes we can!

Karin Martin‐Latry and Bernard Bégaud
Pharmacoepidemiology and Drug Safety 19 (3) 256 (2010)
https://doi.org/10.1002/pds.1912

Comparaison de la consommation de benzodiazépines selon le type d'usage de la buprénorphine dans une cohorte de nouveaux usagers

M Biboulet, M Lapeyre-Mestre and V. Gardette
Pratiques et Organisation des Soins Vol. 41 (3) 205 (2010)
https://doi.org/10.3917/pos.413.0205

Évaluation des prescriptions médicales non conformes dans un service de psychiatrie adulte

Benjamin Bord, Philippe Courtet, Sylvie Hansel, et al.
Thérapie 64 (5) 313 (2009)
https://doi.org/10.2515/therapie/2009037

Comparison of Five Benzodiazepine-Receptor Agonists on Buprenorphine-Induced μ-Opioid Receptor Regulation

Géraldine Poisnel, Martine Dhilly, Reynald Le Boisselier, Louisa Barre and Danièle Debruyne
Journal of Pharmacological Sciences 110 (1) 36 (2009)
https://doi.org/10.1254/jphs.08249FP

Mésusage de médicaments psychotropes au sein d’une population de gardés à vue à Paris

Isabelle Sec, Frank Questel, Caroline Rey and Jean-Louis Pourriat
Thérapie 64 (2) 129 (2009)
https://doi.org/10.2515/therapie/2009016

Estimation of clonazepam abuse liability: a new method using a reimbursed drug database

Elisabeth Frauger, Vanessa Pauly, Xavier Thirion, et al.
International Clinical Psychopharmacology 24 (6) 318 (2009)
https://doi.org/10.1097/YIC.0b013e328330ae4b

Premières journées nationales de pharmacodépendance (CEIP). Place de la pharmacodépendance dans l’évaluation du médicament

Joëlle Micaleff, Pascale Jolliet, Caroline Victorri-Vigneau, et al.
Thérapie 63 (1) 55 (2008)
https://doi.org/10.2515/therapie:2008014